Pfizer Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sales

2,424.76

2,610.99

2,238.55

2,151.65

2,081.50

Operating profit

808.86

835.73

712.12

572.56

565.20

Interest

13.39

10.49

15.11

10.85

1.29

Gross profit

896.52

887.89

778.13

745.73

731.30

EPS (Rs)

136.38

133.89

108.77

111.29

93.78

Other income

101.05

62.65

81.12

184.02

167.39

Stock adjustment

56.48

-72.90

14.35

-36.62

-90.88

Raw material

345.27

354.29

334.74

345.21

343.65

Power and fuel

-

-

-

-

-

Employee expenses

331.68

403.67

361.06

364.51

323.84

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

882.47

1,090.20

816.28

905.99

939.69

Provisions made

-

-

-

-

-

Depreciation

105.51

115.00

109.41

103.24

71.39

Taxation

200.08

160.33

171.11

133.36

230.86

Net profit / loss

623.93

612.56

497.61

509.13

429.05

Extra ordinary item

33.00

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

45.75

45.75

45.75

45.75

45.75

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

33.36

32.01

31.81

26.61

27.15

GPM (%)

35.49

33.21

33.54

31.93

32.52

NPM (%)

24.70

22.91

21.45

21.80

19.08